Metropolis healthcare Limited has announced its quarterly earnings conference call to discuss Q3FY26 financial results. The company informed stock exchanges through a regulatory filing dated January 30, 2026, about the upcoming investor interaction scheduled for February 5, 2026.

Conference Call Details

The earnings call will be held on Thursday, February 5, 2026 at 09:00 AM IST to discuss the company's financial performance for the quarter ended December 31, 2025. ICICI Securities is organizing this post-earnings conference call as part of the company's regular investor engagement activities.

Management Participation

The conference call will feature senior management representatives from Metropolis Healthcare who will discuss the quarterly results and address investor queries.

Access Information

The company has provided multiple access options for participants to join the earnings call. Universal access numbers include +91 22 6280 1144 and +91 22 7115 8045 for domestic participants.

International Access Numbers

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The communication was signed by Kamlesh C Kulkarni, Head – Legal & Secretarial, and sent to both BSE Limited (Scrip Code: 542650) and National Stock Exchange of India Ltd. (Scrip Symbol: METROPOLIS).

ICICI Securities has designated specific coordinators for the call, including Mr. Jaideep Goswami as Head of Equities and Mr. Abdulkader Puranwala for coordination support. Additional contact persons have been provided for clarifications regarding the conference call arrangements.

Metropolis healthcare has completed the allotment of equity shares to employees under its employee stock compensation program. The Nomination and Remuneration Committee approved the allotment through a circular resolution dated January 13, 2026, demonstrating the company's commitment to employee incentivization through equity participation.

Share Allotment Details

The allotment encompasses 9,960 equity shares issued under the Metropolis Restrictive Stock Unit Plan 2020. The key parameters of this allotment are presented below:

Post-Allotment Capital Structure

Following this equity allotment, the company's capital structure has been updated accordingly. The distinctive numbers for the newly allotted shares range from 5,18,21,983 to 5,18,31,942 (both inclusive).

Lock-in Provisions and Share Rights

The allotted equity shares are subject to specific lock-in arrangements designed to ensure employee retention and alignment with company objectives. Under the terms of the MHL-RSU Plan 2020:

• 50% of the equity shares allotted to each RSU holder are subject to lock-in restrictions
• The lock-in period extends for one year from the date of allotment
• Lock-in expiry date is set for January 13, 2027
• All newly allotted shares rank pari-passu with existing equity shares in all respects

Regulatory Compliance

The allotment has been conducted in full compliance with regulatory requirements under SEBI regulations. The company obtained necessary approvals from both BSE Limited (Case No. 130335) and National Stock Exchange of India Ltd. (Application No. 27089). The original filing for the employee benefits scheme was completed on May 23, 2021, with in-principle approvals received from both exchanges in June 2021.

The shares have been issued in dematerialized form and will be available for trading subject to the applicable lock-in provisions. The company has fulfilled all disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.